Nature Portfolio Bioengineering Community
Latest Content
We recently developed a graph deep learning method that considers contextual histopathological features from the whole-slide images. We show that the proposed method can provide interpretable prognostic biomarkers in a semi-supervised manner. We believe it will aid prognostic tasks in the future.
Multiplexed Electrochemical detects both Nucleic acids and Proteins
In this paper, we designed an electrochemical diagnostic device that bridges biology and electronics to simultaneously detect viral RNA and human antibodies for diagnosing and tracking the course of COVID-19 and potentially other infections.
Devora Najjar and 4 others
Aug 18, 2022
From Paper to Industrial-scale Platform: a 3-Year Behind the Paper Journey from GENTRL to Chemistry42
Here we describe the journey from the publication of the research paper demonstrating the proof of concept in generative chemistry with a single model to the industrial-strength multi-AI platform used by the many pharmaceutical companies and first AI-generated compounds in the human clinical trials.
Alex Zhavoronkov and 2 others
Aug 17, 2022
CRISPR Off-Targets: One SNP can make all the difference
In a recent paper, we used ultra-deep sequencing to determine whether CRISPR was introducing or enriching for mutations in cancer genes.
Aug 11, 2022
Brain—Machine Interface: Insights on Sensorimotor Stability from the First Bilateral Microelectrode Array Implants in a Human
Nickl, RW et al. Characteristics and stability of sensorimotor activity driven by isolated-muscle group activation in a human with tetraplegia. Sci Rep 12, 10353 (2022). https://doi.org/10.1038/s41598-022-13436-2
Jul 19, 2022
Wastewater-based epidemiology, or What can sewerage tell us about an ongoing pandemic?
We all produce and discharge excretions into the sewer. Correspondingly, sewerage can tell a lot about its contributory population. In the case of the ongoing COVID-19 pandemic, wastewater-based epidemiology can serve as a tool for population wide pathogen surveillance without compliance issues.
Jul 18, 2022
Featured Contributors
Behind the Paper
The real stories behind the latest research papers, from conception to publication, the highs and the lows.
Graph deep learning detects contextual prognostic biomarkers from whole slide images
We recently developed a graph deep learning method that considers contextual histopathological features from the whole-slide images. We show that the proposed method can provide interpretable prognostic biomarkers in a semi-supervised manner. We believe it will aid prognostic tasks in the future.
Aug 19, 2022
Multiplexed Electrochemical detects both Nucleic acids and Proteins
In this paper, we designed an electrochemical diagnostic device that bridges biology and electronics to simultaneously detect viral RNA and human antibodies for diagnosing and tracking the course of COVID-19 and potentially other infections.
Devora Najjar and 4 others
Aug 18, 2022
Nature Biotech 25th Anniversary
Celebrating 25 years of Nature Biotechnology with posts from authors of landmark papers published in the journal.
Looking back on co-abundance binning and what it meant for microbiomics and its authors
In this post, Dr. Henrik Bjørn Nielsen and Dr. Mathieu Almeida are traveling back in time to talk about their paper on co-abundance binning published in 2014 in Nature Biotechnology and how it affected their field and careers.
Mathieu Almeida and 1 other
Apr 06, 2021
From the Editors
Updates and insights from the bioengineering and biotechnology Editors.
News and Opinion
The latest news, updates, and opinions from across the bioengineering community.
After the Paper
Exploring what happened after the paper was published, from follow up studies to career impact.
From Paper to Industrial-scale Platform: a 3-Year Behind the Paper Journey from GENTRL to Chemistry42
Here we describe the journey from the publication of the research paper demonstrating the proof of concept in generative chemistry with a single model to the industrial-strength multi-AI platform used by the many pharmaceutical companies and first AI-generated compounds in the human clinical trials.
Alex Zhavoronkov and 2 others
Aug 17, 2022
Heart Stem Cell Therapeutics 8.0
Heart Stem Cell Therapeutics 8.0
Kenneth R. Chien and 1 other
Dec 29, 2020
On the Road
Updates from conferences, field work, lab visits, and vacations around the world.
From Cover to Cover
The covers from the monthly issues of Nature Biomedical Engineering.